Carbohydrate-deficient transferrin test
A tool for detecting alcohol abuse
Overall, %CDT is as sensitive as GGT and more sensitive than other biomarkers, including MCV, aspartate transaminase, and alanine transaminase.9 %CDT is more specific than GGT (92% vs. 75%) and other biomarkers. %CDT appears to be more sensitive in men, whereas GGT is more sensitive in women (Table 2).10
Ample evidence, however, suggests that %CDT and GGT readings together may provide a comprehensive picture of recent alcohol abuse.10 Whereas frequent drinking alters %CDT, GGT signals drinking intensity and is more effective at detecting episodic binge drinking (Table 2). This probably explains why problem drinkers age <20—who typically binge-drink—show little or no change in %CDT.
Table 2
%CDT vs GGT testing for recent alcohol abuse
| %CDT | GGT | |
|---|---|---|
| Advantages |
|
|
| Disadvantages |
|
|
| Cutoff value |
|
|
| %CDT: Carbohydrate-deficient transferrin percentage | ||
| GGT: Gamma-glutamyltransferase | ||
FACTORS THAT ALTER RESULTS
Unlike GGT and MCV, few medical conditions distort %CDT,11 meaning the test is accurate in patients with most medical conditions. Only end-stage liver disease, biliary cirrhosis, and rare genetic transferrin variants alter %CDT.
Women tend to have higher and more-variable CDT values than do men, possibly because of variability in normal transferrin levels, anemia secondary to iron deficiency, pregnancy, use of oral contraceptives, or menopause. %CDT cutoff scores are not gender-specific, however, because percentage rather than absolute CDT is typically measured.
%CDT seems to decrease slightly as body mass index increases, suggesting a small but significant inverse relationship between weight and %CDT. Smoking seems to raise %CDT values slightly. The specifics of and reasons for these relationships are unclear.
Related resources
- Axis-Shield. www.axis-shield.com. Click on “Lab diagnostics,” then “Alcohol-related.”
Disclosure
Dr. Anton is a consultant to Axis-Shield.
Dr. Miller and Ms. Dominick report no financial relationship with any company whose products are mentioned in this article, or with manufacturers of competing products.